Topics:

Mood Disorders

Mood Disorders

We have medications that can affect serotonin, norepinephrine, and—to a lesser extent—dopamine. Many other neurotransmitters are involved with mood disorders, but we have no medications yet to target them. Neurostimulation offers a non-systemic somatic approach to depression, often with an improved side effect profile. More in this Q&A.

Persons with epilepsy have a higher prevalence of comorbid conditions—psychiatric disorders in particular—than the general population. Here: a look at the most common comorbidities and a discussion of the clinical implications.

What is the future of psychiatric assessment and treatment of mood disorders? The articles in this Special Report explore some important aspects and issues.

Here: the history of psychotic depression for the Study of the Pharmacotherapy of Psychotic Depression (STOP-PD), a summary its epidemiology, significance, diagnostic complexity, and treatment, as well as case vignettes.

Most, if not all, antidepressants can cause bothersome adverse effects. These are described here along with strategies to help patients cope.

Mood disorders in older adults are neither inevitable nor particularly resistant to treatment. With attention to the special needs of older patients during evaluation, treatment, and follow up, clinicians can help many patients derive greater enjoyment from their later years.

Pages

Subscribe to Mood Disorders on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.